Compositions, methods and uses comprising teneurin c-terminal associated peptide -1 (tcap-1) for enhancing muscle performance

Abstract

The present matter relates to compositions comprising Teneurin C-terminal Associated Peptide - 1 (TCAP-1) and methods and uses of same for enhancing and/or restoring muscle function.

What is claimed is: 
     
         1 . A method for enhancing and/or restoring muscle function in a patient in need thereof comprising administering to a patient in need thereof a therapeutically effective amount of a teneurin c-terminal associated peptide-1 (TCAP-1 peptide), or a pharmaceutically acceptable salt or ester thereof or a pharmaceutical composition comprising same, wherein the amino acid sequence of said TCAP-1 peptide consists essentially of:
 (i) an amino acid sequence having at least 95% identity to an amino acid sequence selected from the group consisting of SEQ ID NOs: 1, 2 or 3; optionally wherein: 
 (a) the carboxy terminal end of said peptide is amidated or comprises an amidation signal sequence; and/or 
 (b) when the amino terminal amino acid of said peptide is a glutamine. 
   
     
     
         2 . The method of  claim 1  wherein the glutamine is in the form of pyroglutamic acid. 
     
     
         3 . The method of  claim 1  wherein the TCAP-1 peptide consists of any one of SEQ. ID. NOs: 1, 2 or 3 which is optionally amidated at the carboxy terminal and wherein the glutamine is optionally a pyroglutamic acid at the amino terminal. 
     
     
         4 . The method of  claim 3  wherein the TCAP-1 is amidated at the carboxy terminal and wherein the glutamine at the amino terminal is a pyroglutamic acid. 
     
     
         5 . The method of  claim 4  wherein the TCAP-1 is SEQ. ID. NO. 1. 
     
     
         6 . The method of  claim 4  wherein the TCAP-1 is SEQ. ID. NO. 2. 
     
     
         7 . The method of  claim 1  wherein the muscle is skeletal muscle. 
     
     
         8 . The method of  claim 1  wherein TCAP-1 enhances calcium clearance from the cytoplasm or the muscle cell cytosol. 
     
     
         9 . The method of  claim 1  wherein enhancing and/or restoring muscle function comprises the ability to enhance contractile performance and/or calcium cycling in muscle cells or tissue. 
     
     
         10 . The method of  claim 1  wherein the enhancing and/or restoring of muscle function comprises restoring calcium cycling and/or for restoring contractile performance in muscle cells. 
     
     
         11 . The method of  claim 1  wherein enhancing or restoring muscle function comprises one or more of the following: shorter recovery time under muscle fatigue conditions, delayed onset of muscle fatigue, longer ability for muscle to sustain contraction or produce force, increased muscle contractile force, prolonged contraction velocity and relaxation rate during fatigue, increased oxidative capacity, and increased calcium handling/cycling. 
     
     
         12 . The method of  claim 1  for treating or preventing skeletal muscle atrophy. 
     
     
         13 . The method of  claim 1  for rehabilitation of skeletal muscle function. 
     
     
         14 . The method of  claim 13  for treating persons who are temporarily or permanently disabled. 
     
     
         15 . The method of  claim 14  wherein the disability is due to hospitalization, illness or accident. 
     
     
         16 . The method of  claim 15  wherein the disability is paralysis. 
     
     
         17 . The method of  claim 1  for reducing muscle recovery time during or after muscle stimulation. 
     
     
         18 . The method of  claim 14 , wherein the stimulation is exercise. 
     
     
         19 . The method of  claim 1  for reducing or delaying onset of fatigue. 
     
     
         20 . The method of  claim 8  for enhancing uptake by the mitochondria and or sarcoplasmic reticulum from the cytosol. 
     
     
         21 - 27 . (canceled)